Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Characterization of cell cycle specific protein interaction networks of the yeast 26S proteasome complex by the QTAX strategy.

Kaake RM, Milenković T, Przulj N, Kaiser P, Huang L.

J Proteome Res. 2010 Apr 5;9(4):2016-29. doi: 10.1021/pr1000175.

3.

Characterization of the proteasome interaction network using a QTAX-based tag-team strategy and protein interaction network analysis.

Guerrero C, Milenkovic T, Przulj N, Kaiser P, Huang L.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13333-8. doi: 10.1073/pnas.0801870105. Epub 2008 Aug 29.

4.

The proteasome-interacting Ecm29 protein disassembles the 26S proteasome in response to oxidative stress.

Wang X, Chemmama IE, Yu C, Huszagh A, Xu Y, Viner R, Block SA, Cimermancic P, Rychnovsky SD, Ye Y, Sali A, Huang L.

J Biol Chem. 2017 Sep 29;292(39):16310-16320. doi: 10.1074/jbc.M117.803619. Epub 2017 Aug 15.

PMID:
28821611
5.

Analyzing cell cycle-dependent degradation and ubiquitination in budding yeast.

Kim DH, Koepp DM.

Methods Mol Biol. 2014;1170:343-56. doi: 10.1007/978-1-4939-0888-2_17.

PMID:
24906322
6.

Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle.

Liu Q, Shang F, Guo W, Hobbs M, Valverde P, Reddy V, Taylor A.

Exp Eye Res. 2004 Feb;78(2):197-205.

PMID:
14729352
7.

Mass spectrometric characterization of the affinity-purified human 26S proteasome complex.

Wang X, Chen CF, Baker PR, Chen PL, Kaiser P, Huang L.

Biochemistry. 2007 Mar 20;46(11):3553-65. Epub 2007 Feb 27.

PMID:
17323924
8.

Timely activation of budding yeast APCCdh1 involves degradation of its inhibitor, Acm1, by an unconventional proteolytic mechanism.

Melesse M, Choi E, Hall H, Walsh MJ, Geer MA, Hall MC.

PLoS One. 2014 Jul 29;9(7):e103517. doi: 10.1371/journal.pone.0103517. eCollection 2014.

9.

Proteomic analysis of the 26S proteasome reveals its direct interaction with transit peptides of plastid protein precursors for their degradation.

Sako K, Yanagawa Y, Kanai T, Sato T, Seki M, Fujiwara M, Fukao Y, Yamaguchi J.

J Proteome Res. 2014 Jul 3;13(7):3223-30. doi: 10.1021/pr401245g. Epub 2014 Jun 4.

PMID:
24846764
10.

Identifying dynamic interactors of protein complexes by quantitative mass spectrometry.

Wang X, Huang L.

Mol Cell Proteomics. 2008 Jan;7(1):46-57. Epub 2007 Oct 12.

11.

Mapping the protein interaction network of the human COP9 signalosome complex using a label-free QTAX strategy.

Fang L, Kaake RM, Patel VR, Yang Y, Baldi P, Huang L.

Mol Cell Proteomics. 2012 May;11(5):138-47. doi: 10.1074/mcp.M111.016352. Epub 2012 Apr 3.

12.

Ubiquitination of specific mitochondrial matrix proteins.

Lehmann G, Ziv T, Braten O, Admon A, Udasin RG, Ciechanover A.

Biochem Biophys Res Commun. 2016 Jun 17;475(1):13-8. doi: 10.1016/j.bbrc.2016.04.150. Epub 2016 May 5.

PMID:
27157140
13.

Interaction of the Doa4 deubiquitinating enzyme with the yeast 26S proteasome.

Papa FR, Amerik AY, Hochstrasser M.

Mol Biol Cell. 1999 Mar;10(3):741-56.

14.
15.
16.

Kip1 degradation via the ubiquitin-proteasome pathway.

Tam SW, Theodoras AM, Pagano M.

Leukemia. 1997 Apr;11 Suppl 3:363-6.

PMID:
9209391
18.

Molecular mechanisms of proteasome assembly.

Murata S, Yashiroda H, Tanaka K.

Nat Rev Mol Cell Biol. 2009 Feb;10(2):104-15. doi: 10.1038/nrm2630. Review.

PMID:
19165213
19.

Proteomics of proteasome complexes and ubiquitinated proteins.

Wang X, Guerrero C, Kaiser P, Huang L.

Expert Rev Proteomics. 2007 Oct;4(5):649-65. Review.

PMID:
17941820
20.

Affinity purification strategy to capture human endogenous proteasome complexes diversity and to identify proteasome-interacting proteins.

Bousquet-Dubouch MP, Baudelet E, Guérin F, Matondo M, Uttenweiler-Joseph S, Burlet-Schiltz O, Monsarrat B.

Mol Cell Proteomics. 2009 May;8(5):1150-64. doi: 10.1074/mcp.M800193-MCP200. Epub 2009 Feb 3.

Supplemental Content

Support Center